Incorrect release of the active substance from the medicinal product, to an extent that may affect its therapeutic properties, constitutes a real risk to patients' health due to the potential lack of efficacy. Potential effects: ineffective treatment of infections, risk of disease progression or complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the medicine from batches 10421 and 10421A, check the batch number on the pack, return the product to the pharmacy if you have it, and consult your doctor regarding further treatment.
The batches 10421 and 10421A of Linezolid Polpharma 600 mg were withdrawn from the market nationwide, their placing on the market was prohibited, the decision was given immediate enforceability, and t...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related